Celltrion Pharm, Inc. (KOSDAQ:068760)

Celltrion Pharm Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue Revenue Growth	274,731	233,568	173,513	146,880	135,860	104,811
Revenue Growth	53.21%	34.61%	18.13%	8.11%	29.62%	40.25%
Gross Profit Gross Profit Growth	80,842	72,933	62,239	40,372	58,088	41,863
Operating Income Operating Income Growth	28,885	23,631	14,739	3,166	8,613	-15,085
Net Income Net Income Growth	26,026	20,940	8,602	-9,389	15,715	-21,106
Earnings Per Share EPS Growth	583.36	469.96	193.47	-211.89	359.53	-569.87
EPS Growth	146.02%	142.92%	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea South Korea Growth	273,611	231,982	172,298	145,913	133,716	101,809
Vietnam Vietnam Growth	-	138.91	61.78	35.35	393.12	864.55
Kazakhstan Kazakhstan Growth	543.04	566.66	343.49	390.4	414.15	359.33
Republic of The Philippines Republic of The Philippines Growth	223.31	595.89	673.54	364.16	1,047	1,322
Other Other Growth	260.98	284.99	135.58	176.83	273.2	423.85
Total Total Growth	274,731	233,568	173,513	146,880	135,860	104,811

Cash & Debt

Chart

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Investments Cash & Investments Growth	34,628	29,748	13,332	9,118	5,953	10,510
Total Debt Total Debt Growth	191,750	193,022	161,885	146,978	144,249	138,732
Net Cash (Debt) Net Cash Growth	-157,123	-163,274	-148,554	-137,860	-138,296	-128,222
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-3522.39	-3663.28	-3339.19	-3111.09	-3164.03	-3462.05

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Operating Cash Flow Operating Cash Flow Growth	28,435	36,246	27,855	14,313	-10,163	-26,209
Capital Expenditures CapEx Growth	-30,616	-41,978	-30,488	-7,207	-1,079	-2,085
Free Cash Flow Free Cash Flow Growth	-2,181	-5,731	-2,633	7,106	-11,242	-28,294
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Gross Margin	29.43%	31.23%	35.87%	27.49%	42.76%	39.94%
Operating Margin	10.51%	10.12%	8.49%	2.15%	6.34%	-14.39%
Pretax Margin	9.16%	8.62%	5.10%	-4.26%	11.38%	-22.37%
Profit Margin	9.47%	8.96%	4.96%	-6.39%	11.57%	-20.14%
FCF Margin	-0.79%	-2.45%	-1.52%	4.84%	-8.28%	-27.00%

Valuation

Chart

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Aug 11, 2026	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
PE Ratio	77.14	415.74	165.49	-	132.39	-
P/FCF Ratio	-	-	-	304.21	-	-
PS Ratio	7.24	37.27	8.21	14.72	15.31	7.58

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2021

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error